98%
921
2 minutes
20
The mechanisms that balance a robust intrinsic antiviral defense at the maternal-fetal interface with fetal development remain elusive. Here, it is delineated that ADAR1, an adenosine-to-inosine (A-to-I) editor, fine-tunes intrinsic interferon (IFN)-mediated integrates stress response (ISR) in the mouse placenta, thereby orchestrating embryonic development and antiviral defense. Placental Adar1 deletion (Adar1) trigger spatially resolved overwhelming IFN responses, which impair the differentiation of IFN hyper-responsive junctional zone (JZ) progenitors and functions of the placental JZ, ultimately causing embryonic death. Mechanistically, the Adar1 placental IFN hyper-response is positively amplified by the accumulated immunogenic dsRNAs from the 3'UTR of interferon-stimulated genes (ISG-3'UTR-dsRNA). The resulting fetal death is rescued by concurrent deletion of Mavs, Ifnar1, or Pkr, but not Zbp1 or cell death effectors. Notably, blocking ISR pharmacologically preventes embryonic lethality induced by Adar1 JZ defects. These findings demonstrate that ADAR1 fine-tunes the unique spatially resolved IFN-PKR-ISR signaling in the placenta by restricting ISG-3'UTR-dsRNA accumulation, highlighting a potential therapeutic strategy for treating interferonopathy-associated pregnancy complications.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/advs.202505491 | DOI Listing |
Adv Sci (Weinh)
August 2025
Fujian Provincial Key Laboratory of Reproductive Health Research, Cancer Research Center, Department of Obstetrics and Gynecology, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, Fujian, 361102, China.
The mechanisms that balance a robust intrinsic antiviral defense at the maternal-fetal interface with fetal development remain elusive. Here, it is delineated that ADAR1, an adenosine-to-inosine (A-to-I) editor, fine-tunes intrinsic interferon (IFN)-mediated integrates stress response (ISR) in the mouse placenta, thereby orchestrating embryonic development and antiviral defense. Placental Adar1 deletion (Adar1) trigger spatially resolved overwhelming IFN responses, which impair the differentiation of IFN hyper-responsive junctional zone (JZ) progenitors and functions of the placental JZ, ultimately causing embryonic death.
View Article and Find Full Text PDFPlacenta
August 2024
Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Proc Natl Acad Sci U S A
January 2011
Department of Veterinary Pathobiology, University of Missouri, Columbia, MO 65211, USA.
Upregulation of ADAM-12, a novel member of the multifunctional ADAM family of proteins is linked to cancer, arthritis and cardiac hypertrophy. Basal expression of ADAM-12 is very low in adult tissues but rises markedly in response to certain physiological cues, such as during pregnancy in the placenta, during development in neonatal skeletal muscle and bone and in regenerating muscle. Studies on ADAM-12 regulation have identified a highly conserved negative regulatory element (NRE) at the 5'-UTR of human ADAM-12 gene, which acts as a transcriptional repressor.
View Article and Find Full Text PDFGene
November 2000
Department of Molecular, Cellular, and Developmental Biology and Interdepartmental Graduate Program of Biochemistry and Molecular Biology, University of California, Santa Barbara, CA 93106, USA.
The human ADAR1 gene specifies two size forms of RNA-specific adenosine deaminase, an interferon (IFN) inducible approximately 150 kDa protein and a constitutively expressed N-terminally truncated approximately 110 kDa protein, encoded by transcripts with alternative exon 1 structures that initiate from different promoters. We have now identified a new class of ADAR1 transcripts, with alternative 5'-structures and a deduced coding capacity for the approximately 110 kDa protein. Nuclease protection and 5'-rapid amplification of cDNA ends (5'-RACE) revealed five major ADAR1 transcriptional start sites that mapped within the previously identified and unusually large (approximately 1.
View Article and Find Full Text PDFProc Natl Acad Sci U S A
April 1999
Department of Molecular, Cellular, and Developmental Biology, University of California, Santa Barbara, CA 93106, USA.
RNA-specific adenosine deaminase (ADAR1) catalyzes the deamination of adenosine to inosine in viral and cellular RNAs. Two size forms of the ADAR1 editing enzyme are known, an IFN-inducible approximately 150-kDa protein and a constitutively expressed N-terminally truncated approximately 110-kDa protein. We have now identified alternative exon 1 structures of human ADAR1 transcripts that initiate from unique promoters, one constitutively expressed and the other IFN inducible.
View Article and Find Full Text PDF